InterVivo Solutions Provides Update on Cooperative Psychedelics Evaluation Platform (COPE) - Names Drs. Inés De Lannoy and Lilia Magomedova to Lead Bioanalytical Platform Development
Toronto, Ontario--(Newsfile Corp. - June 12, 2021) - InterVivo Solutions (IVS) today announced availability of its first data set as part of the COPETM program. The program, launched in March, in collaboration
Source: finanznachrichten.de